Evaluating the Mediterranean diet in patients with kidney stones and bone diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess how well patients with recurrent kidney stones and osteometabolic diseases adhere to the Mediterranean diet. By evaluating dietary habits, the study seeks to gather crucial data that can inform dietary management strategies for these conditions. The findings may help in developing effective dietary approaches for the prevention of recurrent kidney stones and related health issues. The study will involve patients who have experienced multiple kidney stones in the past five years.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with idiopathic relapsing nephrolithiasis with evidence instrumental of bilateral renal stones or emission of more than one stone in the past 5 years

Exclusion Criteria:

* Patients who had albumin-corrected plasma calcium levels \> 11.0 mg/dl at the time of the first determination of serum levels of 25 OH vitamin D;
* Patients who had glomerular filtration rate \< 60 mL/min/1.73 m2;
* Patients who had positive personal history of chronic granulomatous disease;
* pregnancy patients;
* Positive personal history for morphological abnormalities of the excretory system;
* incomplete data collection.

Where it's running

• Irccs Synlab Sdn
  Naples, Italy Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Tamsulosin and intraureteral aminophylline to improve ureteral access during primary retrograde intrarenal surgery

  This trial tests whether taking tamsulosin before surgery, using aminophylline inside the ureter during the operation, or both, helps place the ureteral access sheath on the first try for adults with small unilateral kidney stones undergoing RIRS.

  Recruiting at 3 sites Phase 2 Beni-Suef University · Aswān, Aswan Governorate and 2 other locations · NCT07623876

• Abdominal CT offered alongside lung screening for people who have smoked

  We will test whether mentioning a possible extra abdominal CT in the lung screening invitation changes whether people aged 55–70 who have ever smoked attend their lung screening appointment.

  Recruiting University of Cambridge · Hull · NCT07171190

• Stone clearance with steerable ureteroscopic evacuation compared with other methods

  This study tests whether the CVAC/SURE approach helps clear kidney stones more effectively than standard renal-stone interventions in patients needing ureteroscopy or PCNL.

  Recruiting at 10 sites Calyxo, Inc. · Miami, Florida and 9 other locations · NCT07155005

• Steerable Ureteroscopic Renal Evacuation (SURE) with CVAC vs standard ureteroscopy

  This trial tests whether the SURE system with CVAC can improve outcomes compared with standard ureteroscopy with laser lithotripsy for kidney stones in adult patients.

  Recruiting at 6 sites Calyxo, Inc. · Birmingham, Alabama and 5 other locations · NCT07101809

• Retrograde renal access with RetroPerc for percutaneous kidney stone removal

  This study tries RetroPerc® to obtain kidney access during supine percutaneous nephrolithotomy in adults with 1.5–3 cm kidney stones.

  Recruiting at 2 sites University of Kansas Medical Center · Tampa, Florida and 1 other locations · NCT07071831

• Flexible Ureteroscopy With Navigable Suction vs Mini-PCNL in Kids with Kidney Stones

  This study tests whether flexible ureteroscopy with suction helps treat kidney stones in children compared with mini-percutaneous nephrolithotomy.

  Recruiting Ain Shams University · Cairo, Abbasia · NCT07763743

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.